Ledger.Open graph →
SEC Form D · filed October 26, 2020

Solid Biosciences Inc

Offering
$40.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (41)

Martin Freed · Cambridge, MADirectorLynne Sullivan · Boston, MADirectorAdam Stone · Mamaroneck, NYDirectorMatthew Arnold · Houston, TXDirectorRajeev Shah · San Francisco, CADirectorSukumar Nagendran · Cambridge, MADirectorAdam Koppel · Cambridge, MADirectorRobert Huffines · Cambridge, MADirectorJoel Schneider · Cambridge, MAExecCarl Morris · Cambridge, MAExecLynette Herscha · Cambridge, MAExecIlan Ganot · Cambridge, MAExec · DirectorJennifer Ziolkowski · Cambridge, MAExecDavid Shainok · New York, NYDirectorLuke Walker · WILMINGTON, DEDirectorLisa Audet · Greenwich, CTExecJared Kehe · Allston, MAExecPavel Livshiz · New York, NYDirectorMartin A. Freed · Cambridge, MADirectorSamuel B. Cates · Boston, MAExec · DirectorAdam Mullinax · Boston, MAExecRajeev A. Shah · Cambridge, MADirectorLorenzo Delzoppo · WILMINGTON, DEDirectorMark Goode · WILMINGTON, DEDirectorRon Efroni Rotman · New York, NYDirectorJeffrey B. Beir · Boston, MAExecIan Smith · New York, NYDirectorChris M. Rosenthal · BALTIMORE, MDDirectorWayne M. Rehberger · BALTIMORE, MDDirectorKeith M. Jackson · BALTIMORE, MDDirectorTom Werthan · BALTIMORE, MDDirectorAndrew Gavin · BALTIMORE, MDDirectorCharles Boatin · Saint-Pierre, O4DirectorFlorent De Boissieu · Saint-Pierre, O4DirectorStephane Bacquaert · Saint-Pierre, O4DirectorMartha Osier · Saint-Pierre, O4ExecNnennia Ejebe · Saint-Pierre, O4ExecAlexis Caude · Saint-Pierre, O4ExecChristophe Scalbert · Saint-Pierre, O4Exec · DirectorAntoine Delaporte · Saint-Pierre, O4ExecIan Smith · Windermere, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗